ADALIMUMAB-AFZB

ADALIMUMAB-AFZB was reported 2683 times

ADALIMUMAB-AFZB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BLADDER DIVERTICULITIS 2 0.1176
1 THIOPURINE METHYLTRANSFERASE DECREASED 3 0.0882
2 LACK OF INFUSION SITE ROTATION 3 0.0625
3 PATIENT-DEVICE INTERACTION ISSUE 2 0.0408
4 ILEOCOLECTOMY 4 0.0400
5 FAECAL CALPROTECTIN DECREASED 3 0.0385
6 ANAL CYST 2 0.0345
7 PILONIDAL DISEASE 5 0.0208
8 GINGIVAL GRAFT 2 0.0177
9 ILEOCAECAL RESECTION 6 0.0174
10 PATIENT-DEVICE INCOMPATIBILITY 10 0.0146
11 EXCESSIVE SKIN 4 0.0142
12 PERINATAL DEPRESSION 6 0.0133
13 FAECAL CALPROTECTIN INCREASED 42 0.0132
14 ILEAL ULCER 11 0.0109
15 INJECTION SITE HYPERAESTHESIA 2 0.0103
16 BUTTOCK INJURY 3 0.0098
17 GREATER TROCHANTERIC PAIN SYNDROME 2 0.0098
18 ANAL FISSURE 52 0.0097
19 ARTHRITIS ENTEROPATHIC 3 0.0092
20 DEVICE MECHANICAL ISSUE 122 0.0089
21 STOMA OBSTRUCTION 2 0.0087
22 ANASTOMOTIC ULCER 4 0.0087
23 INJECTION SITE NERVE DAMAGE 2 0.0084
24 MORPHOEA 4 0.0083
25 PARANASAL CYST 2 0.0082
26 NOSE DEFORMITY 3 0.0081
27 BRONCHITIS BACTERIAL 6 0.0079
28 FISTULA DISCHARGE 10 0.0079
29 PYODERMA 4 0.0079
30 ANAL ABSCESS 42 0.0078
31 EYELID OPERATION 2 0.0075
32 PRODUCT SUBSTITUTION 3 0.0074
33 VAGINAL ABSCESS 2 0.0074
34 COLON DYSPLASIA 2 0.0070
35 POUCHITIS 6 0.0070
36 SUSPECTED OFF LABEL USE 31 0.0069
37 INFUSION SITE SCAR 3 0.0068
38 GASTROINTESTINAL MUCOSA HYPERAEMIA 2 0.0068
39 JOINT SPACE NARROWING 2 0.0067
40 SPONDYLOARTHROPATHY 4 0.0067
41 SINUSITIS BACTERIAL 7 0.0066
42 CORNEAL LESION 2 0.0065
43 SKIN BACTERIAL INFECTION 5 0.0062
44 INTESTINAL ANASTOMOSIS 4 0.0062
45 NODAL OSTEOARTHRITIS 2 0.0062
46 ABDOMINOPLASTY 2 0.0060
47 LOWER RESPIRATORY TRACT INFECTION VIRAL 3 0.0059
48 UVEITIS 79 0.0058
49 LIGAMENT OPERATION 2 0.0058
50 FISTULA 64 0.0057
51 INFECTED FISTULA 3 0.0056
52 PSEUDOPOLYP 2 0.0056
53 ABSCESS BACTERIAL 2 0.0055
54 ANASTOMOTIC STENOSIS 2 0.0054
55 TONSILLAR DISORDER 6 0.0053
56 WISDOM TEETH REMOVAL 7 0.0053
57 LUNG CYST 2 0.0051
58 GROIN ABSCESS 6 0.0051
59 ILEOSTOMY 13 0.0051
60 DRUG LEVEL BELOW THERAPEUTIC 28 0.0051
61 SACRAL PAIN 3 0.0049
62 SITTING DISABILITY 3 0.0049
63 FAECAL CALPROTECTIN ABNORMAL 2 0.0048
64 FISTULA OF SMALL INTESTINE 2 0.0048
65 TEMPOROMANDIBULAR PAIN AND DYSFUNCTION SYNDROME 2 0.0047
66 C-REACTIVE PROTEIN DECREASED 3 0.0046
67 TISSUE INJURY 2 0.0046
68 ABSCESS 71 0.0044
69 PYODERMA GANGRENOSUM 16 0.0044
70 GASTROINTESTINAL STENOSIS 2 0.0044
71 DISCHARGE 6 0.0043
72 STOMA CREATION 3 0.0043
73 ERYTHEMA NODOSUM 15 0.0043
74 DEVICE DISPENSING ERROR 5 0.0042
75 DEFAECATION URGENCY 29 0.0041
76 ANAL FISTULA 22 0.0041
77 DRAINAGE 2 0.0041
78 INTRAOCULAR LENS IMPLANT 2 0.0040
79 PHARYNGEAL ABSCESS 2 0.0040
80 AXILLARY MASS 4 0.0038
81 DRUG LEVEL ABNORMAL 2 0.0038
82 DRUG LEVEL DECREASED 37 0.0036
83 EYE INFECTION BACTERIAL 2 0.0036
84 URINARY TRACT INFECTION BACTERIAL 9 0.0036
85 INTESTINAL STENOSIS 15 0.0036
86 TYMPANIC MEMBRANE PERFORATION 6 0.0035
87 METABOLIC SURGERY 4 0.0035
88 APHTHOUS ULCER 26 0.0033
89 FIBROMA 3 0.0033
90 STAPHYLOCOCCAL SKIN INFECTION 4 0.0033
91 DRUG SPECIFIC ANTIBODY PRESENT 21 0.0032
92 ELBOW OPERATION 2 0.0032
93 INTESTINAL ULCER 5 0.0031
94 DEVICE DEFECTIVE 54 0.0031
95 DEVICE SAFETY FEATURE ISSUE 3 0.0030
96 GINGIVAL DISCOMFORT 2 0.0030
97 ANORECTAL DISORDER 6 0.0030
98 VAGINAL INFECTION 14 0.0030
99 STOMA COMPLICATION 3 0.0030
100 ANGULAR CHEILITIS 2 0.0029
101 INGROWN HAIR 2 0.0029
102 ANASTOMOTIC LEAK 2 0.0029
103 FUNGAL OESOPHAGITIS 2 0.0028
104 PUNCTURE SITE HAEMORRHAGE 2 0.0028
105 ILEAL STENOSIS 5 0.0028
106 DEVICE OPERATIONAL ISSUE 12 0.0028
107 NASAL INJURY 2 0.0028
108 ANAL INCONTINENCE 24 0.0027
109 SACROILIITIS 5 0.0026
110 BLOODY DISCHARGE 3 0.0026
111 MUCOUS STOOLS 13 0.0026
112 OCULAR HYPERTENSION 5 0.0026
113 DISCOURAGEMENT 6 0.0026
114 INFECTION PARASITIC 2 0.0026
115 RECTAL ULCER 3 0.0026
116 INTESTINAL OPERATION 4 0.0025
117 THERAPEUTIC RESPONSE SHORTENED 83 0.0025
118 POLYPECTOMY 2 0.0025
119 PANCREATITIS RELAPSING 2 0.0024
120 INTESTINAL RESECTION 13 0.0024
121 DRUG LEVEL ABOVE THERAPEUTIC 11 0.0024
122 RECTAL ABSCESS 4 0.0024
123 TONSILLAR HYPERTROPHY 4 0.0024
124 INFUSION SITE IRRITATION 3 0.0023
125 CRANIOFACIAL FRACTURE 2 0.0023
126 SERUM FERRITIN DECREASED 4 0.0023
127 ABDOMINAL OPERATION 3 0.0023
128 ABSCESS DRAINAGE 2 0.0023
129 FEAR OF INJECTION 16 0.0022
130 SPONDYLITIS 8 0.0022
131 POOR QUALITY DEVICE USED 22 0.0022
132 THERAPEUTIC PRODUCT EFFECT DELAYED 10 0.0022
133 BONE CYST 2 0.0021
134 INJECTION SITE HYPOAESTHESIA 3 0.0021
135 CONDITION AGGRAVATED 636 0.0021
136 LYMPHADENECTOMY 2 0.0020
137 NEEDLE ISSUE 59 0.0020
138 PROCTALGIA 13 0.0020
139 AXILLARY PAIN 3 0.0020
140 LARGE INTESTINAL STENOSIS 4 0.0020
141 SUPERINFECTION 3 0.0020
142 TESTICULAR DISORDER 2 0.0020
143 BREAST ABSCESS 2 0.0020
144 PALLIATIVE CARE 3 0.0020
145 BONE MARROW OEDEMA 2 0.0019
146 JOINT DESTRUCTION 3 0.0019
147 INTERVERTEBRAL DISC COMPRESSION 2 0.0019
148 DEVICE LEAKAGE 83 0.0019
149 SENSITIVITY TO WEATHER CHANGE 10 0.0019
150 NASAL INFLAMMATION 2 0.0019
151 ABSCESS LIMB 8 0.0019
152 SCLERITIS 3 0.0019
153 DRUG DOSE OMISSION BY DEVICE 145 0.0018
154 LARGE INTESTINAL ULCER 5 0.0018
155 LYME DISEASE 6 0.0018
156 MEAN CELL HAEMOGLOBIN CONCENTRATION DECREASED 3 0.0018
157 TONSILLECTOMY 3 0.0018
158 VEIN RUPTURE 3 0.0018
159 INJECTION SITE OEDEMA 3 0.0017
160 EXPOSURE VIA SKIN CONTACT 45 0.0017
161 EPIDIDYMITIS 2 0.0017
162 BREAST CYST 3 0.0017
163 BLOOD IRON DECREASED 20 0.0017
164 INFECTED CYST 2 0.0017
165 OPHTHALMIC HERPES ZOSTER 3 0.0017
166 FAECES SOFT 12 0.0016
167 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 116 0.0016
168 STREPTOCOCCAL INFECTION 9 0.0016
169 INJECTION SITE CELLULITIS 3 0.0016
170 CHRONIC SINUSITIS 6 0.0016
171 INTESTINAL OBSTRUCTION 60 0.0016
172 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 2 0.0016
173 DEVICE FAILURE 24 0.0016
174 IRON DEFICIENCY 7 0.0016
175 NASAL SEPTUM DEVIATION 3 0.0015
176 HIDRADENITIS 14 0.0015
177 EAR DISORDER 7 0.0015
178 COLOSTOMY 3 0.0015
179 LIP INJURY 2 0.0015
180 ENCEPHALITIS AUTOIMMUNE 2 0.0015
181 EYE OPERATION 7 0.0015
182 PHARYNGEAL ULCERATION 2 0.0015
183 ANORECTAL DISCOMFORT 8 0.0015
184 SKIN DISCOMFORT 4 0.0015
185 EAR CONGESTION 4 0.0015
186 CALCULUS BLADDER 2 0.0015
187 CLUSTER HEADACHE 2 0.0015
188 DRUG SPECIFIC ANTIBODY 2 0.0015
189 CHOLANGITIS SCLEROSING 3 0.0015
190 ABSCESS ORAL 2 0.0015
191 INCORRECT DOSE ADMINISTERED BY DEVICE 38 0.0014
192 HAEMATOCHEZIA 80 0.0014
193 BOWEL MOVEMENT IRREGULARITY 11 0.0014
194 PROCTITIS 4 0.0014
195 ENTERITIS 9 0.0014
196 DEVICE DELIVERY SYSTEM ISSUE 38 0.0014
197 NONINFECTIVE GINGIVITIS 2 0.0014
198 SKIN STRIAE 2 0.0013
199 INFUSION SITE REACTION 4 0.0013
200 GASTROINTESTINAL WALL THICKENING 2 0.0013
201 EPICONDYLITIS 2 0.0013
202 DYSCHEZIA 4 0.0013
203 ANKYLOSING SPONDYLITIS 17 0.0013
204 RESPIRATORY TRACT INFECTION VIRAL 3 0.0013
205 SINUS PAIN 3 0.0013
206 MOUTH ULCERATION 27 0.0013
207 GASTROINTESTINAL STOMA COMPLICATION 2 0.0013
208 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 3 0.0013
209 PHARYNGEAL PARAESTHESIA 2 0.0013
210 LOSS OF THERAPEUTIC RESPONSE 4 0.0013
211 DEVICE DEPLOYMENT ISSUE 16 0.0013
212 SUBCUTANEOUS ABSCESS 6 0.0013
213 OBSTRUCTION 5 0.0013
214 PNEUMONIA LEGIONELLA 2 0.0012
215 IMMUNOSUPPRESSION 11 0.0012
216 HERNIA 24 0.0012
217 EYE INFECTION 14 0.0012
218 INJECTION SITE DISCOMFORT 13 0.0012
219 SHOULDER FRACTURE 2 0.0012
220 INFUSION SITE HAEMORRHAGE 4 0.0012
221 FOOT OPERATION 6 0.0012
222 CYST 15 0.0012
223 FREQUENT BOWEL MOVEMENTS 32 0.0012
224 PRODUCT CONTAMINATION PHYSICAL 3 0.0012
225 HAEMORRHOIDS 23 0.0012
226 ENTERITIS INFECTIOUS 2 0.0012
227 THYROIDECTOMY 2 0.0012
228 TOOTH INJURY 5 0.0012
229 POSTMENOPAUSAL HAEMORRHAGE 3 0.0011
230 INGUINAL HERNIA 7 0.0011
231 TONSILLITIS 6 0.0011
232 MASTECTOMY 2 0.0011
233 LACK OF INJECTION SITE ROTATION 2 0.0011
234 GASTROINTESTINAL OEDEMA 2 0.0011
235 PHARYNGITIS 14 0.0011
236 HIP ARTHROPLASTY 17 0.0011
237 SYNOVITIS 20 0.0011
238 FOOD INTOLERANCE 4 0.0011
239 NODULE 14 0.0011
240 RECTAL HAEMORRHAGE 46 0.0011
241 SKIN INFECTION 12 0.0011
242 COLECTOMY 6 0.0011
243 CLOSTRIDIUM DIFFICILE INFECTION 23 0.0011
244 DEVICE PHYSICAL PROPERTY ISSUE 8 0.0010
245 BREAST MASS 7 0.0010
246 LIMB OPERATION 5 0.0010
247 TRAUMATIC LUNG INJURY 2 0.0010
248 DEVICE USE ISSUE 18 0.0010
249 PHARYNGITIS STREPTOCOCCAL 11 0.0010
250 LARGE INTESTINE POLYP 7 0.0010
251 KERATITIS 3 0.0010
252 CHEST INJURY 2 0.0010
253 ANAL PRURITUS 2 0.0010
254 INJECTION SITE HYPERSENSITIVITY 3 0.0010
255 BLOOD CREATININE DECREASED 3 0.0010
256 ABDOMINAL ADHESIONS 3 0.0009
257 KNEE ARTHROPLASTY 20 0.0009
258 IRIDOCYCLITIS 3 0.0009
259 SENSITIVE SKIN 7 0.0009
260 OFF LABEL USE 824 0.0009
261 INCORRECT DRUG ADMINISTRATION RATE 4 0.0009
262 JOINT INJURY 20 0.0009
263 ABSCESS INTESTINAL 2 0.0009
264 HORDEOLUM 4 0.0009
265 HIP SURGERY 5 0.0009
266 DEVICE OCCLUSION 13 0.0009
267 MONOPLEGIA 4 0.0009
268 LIMB INJURY 25 0.0009
269 SKIN LACERATION 10 0.0009
270 POLYP 6 0.0009
271 KNEE OPERATION 9 0.0009
272 DIVERTICULUM INTESTINAL 4 0.0009
273 MELANOCYTIC NAEVUS 4 0.0009
274 TOOTH INFECTION 12 0.0009
275 C-REACTIVE PROTEIN INCREASED 33 0.0009
276 FOOT FRACTURE 17 0.0009
277 COLITIS ULCERATIVE 40 0.0009
278 INFECTIOUS MONONUCLEOSIS 2 0.0009
279 POSTOPERATIVE WOUND INFECTION 6 0.0009
280 FEEDING DISORDER 18 0.0009
281 FURUNCLE 7 0.0009
282 WOUND COMPLICATION 3 0.0009
283 HEPATIC FIBROSIS 3 0.0009
284 CYTOMEGALOVIRUS COLITIS 2 0.0009
285 CERVICAL VERTEBRAL FRACTURE 3 0.0009
286 POST PROCEDURAL INFECTION 7 0.0009
287 CARPAL TUNNEL SYNDROME 12 0.0009
288 UMBILICAL HERNIA 4 0.0009
289 ORAL SURGERY 2 0.0009
290 INGROWING NAIL 2 0.0008
291 PUSTULE 2 0.0008
292 SINUS OPERATION 2 0.0008
293 ENDOMETRIOSIS 4 0.0008
294 EYE INFLAMMATION 8 0.0008
295 POOR QUALITY SLEEP 18 0.0008
296 IMMUNE SYSTEM DISORDER 11 0.0008
297 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 40 0.0008
298 GASTROINTESTINAL OBSTRUCTION 2 0.0008
299 PAINFUL RESPIRATION 2 0.0008
300 BREATH ODOUR 2 0.0008
301 INFLAMMATORY BOWEL DISEASE 8 0.0008
302 DEVICE DIFFICULT TO USE 54 0.0008
303 EYE OEDEMA 2 0.0008
304 RECTAL DISCHARGE 3 0.0008
305 WOUND HAEMORRHAGE 3 0.0008
306 DENTAL OPERATION 2 0.0008
307 DRUG EFFECT LESS THAN EXPECTED 12 0.0008
308 INJECTION SITE ABSCESS 2 0.0008
309 INFREQUENT BOWEL MOVEMENTS 2 0.0008
310 MATERNAL EXPOSURE TIMING UNSPECIFIED 3 0.0008
311 SNORING 3 0.0008
312 CHOLECYSTECTOMY 9 0.0008
313 CLAVICLE FRACTURE 3 0.0008
314 ILLNESS 80 0.0008
315 LIPOMA 2 0.0008
316 FAECES HARD 3 0.0008
317 URINE OUTPUT INCREASED 2 0.0008
318 WEIGHT FLUCTUATION 8 0.0008
319 NEPHROLITHIASIS 35 0.0008
320 LUNG OPACITY 2 0.0008
321 IRON DEFICIENCY ANAEMIA 7 0.0008
322 VIRAL INFECTION 25 0.0008
323 ANIMAL BITE 2 0.0007
324 ABDOMINAL MASS 2 0.0007
325 INJECTION SITE DISCHARGE 4 0.0007
326 GALLBLADDER OPERATION 3 0.0007
327 BEHAVIOUR DISORDER 4 0.0007
328 SPUTUM DISCOLOURED 7 0.0007
329 IMMUNODEFICIENCY 11 0.0007
330 INJURY ASSOCIATED WITH DEVICE 15 0.0007
331 ABNORMAL FAECES 6 0.0007
332 ARTHRITIS BACTERIAL 3 0.0007
333 JOINT EFFUSION 5 0.0007
334 BLOOD PRESSURE SYSTOLIC INCREASED 14 0.0007
335 APHONIA 10 0.0007
336 ELECTRIC SHOCK SENSATION 2 0.0007
337 ANAL HAEMORRHAGE 2 0.0007
338 BODY TEMPERATURE DECREASED 7 0.0007
339 PERIORBITAL SWELLING 4 0.0007
340 PRODUCT DOSE OMISSION IN ERROR 20 0.0007
341 SHOULDER OPERATION 3 0.0007
342 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 126 0.0007
343 TEARFULNESS 3 0.0007
344 PHARYNGEAL DISORDER 2 0.0007
345 LUNG CANCER METASTATIC 2 0.0007
346 HEPATIC CIRRHOSIS 13 0.0007
347 MAJOR DEPRESSION 5 0.0007
348 FEELING OF BODY TEMPERATURE CHANGE 4 0.0007
349 EAR DISCOMFORT 7 0.0007
350 GINGIVAL SWELLING 3 0.0007
351 ABDOMINAL ABSCESS 3 0.0007
352 ARTHROPOD BITE 5 0.0007
353 URINE ANALYSIS ABNORMAL 2 0.0007
354 WRIST FRACTURE 8 0.0007
355 HEAVY MENSTRUAL BLEEDING 6 0.0007
356 URINARY TRACT DISORDER 3 0.0007
357 SCRATCH 7 0.0007
358 BONE MARROW DISORDER 2 0.0007
359 BURSITIS 8 0.0007
360 INFLAMMATION 34 0.0007
361 IRITIS 2 0.0007
362 DEVICE MALFUNCTION 46 0.0007
363 RECTAL CANCER 2 0.0007
364 SMALL INTESTINAL OBSTRUCTION 8 0.0006
365 SPINAL FRACTURE 13 0.0006
366 ANKLE FRACTURE 10 0.0006
367 TOOTH EXTRACTION 8 0.0006
368 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 30 0.0006
369 EYELIDS PRURITUS 2 0.0006
370 TIBIA FRACTURE 3 0.0006
371 WOUND INFECTION 7 0.0006
372 GASTROINTESTINAL INFLAMMATION 5 0.0006
373 SKIN ABRASION 3 0.0006
374 RED BLOOD CELL SEDIMENTATION RATE INCREASED 7 0.0006
375 INTENTIONAL DOSE OMISSION 18 0.0006
376 GINGIVAL PAIN 5 0.0006
377 POST PROCEDURAL COMPLICATION 12 0.0006
378 HUMERUS FRACTURE 3 0.0006
379 FLATULENCE 35 0.0006
380 OROPHARYNGEAL PAIN 57 0.0006
381 HAEMORRHOIDAL HAEMORRHAGE 3 0.0006
382 BACTERIAL SEPSIS 2 0.0006
383 EATING DISORDER 13 0.0006
384 COVID-19 107 0.0006
385 INJECTION SITE INFECTION 2 0.0006
386 INFLAMMATORY MARKER INCREASED 3 0.0006
387 EAR INFECTION 16 0.0006
388 ABDOMINAL PAIN 139 0.0006
389 TOOTH ABSCESS 6 0.0006
390 RIB FRACTURE 12 0.0006
391 TENDONITIS 9 0.0006
392 TRISMUS 3 0.0006
393 NASAL CONGESTION 34 0.0006
394 GRANULOMA 2 0.0006
395 NASOPHARYNGITIS 106 0.0006
396 THROMBOPHLEBITIS 2 0.0006
397 EAR PRURITUS 2 0.0006
398 SPINAL OPERATION 7 0.0006
399 HEAD DISCOMFORT 10 0.0006
400 INJECTION SITE PAIN 173 0.0006
401 KIDNEY INFECTION 11 0.0006
402 FOOD POISONING 3 0.0006
403 IMPAIRED QUALITY OF LIFE 8 0.0006
404 ABDOMINAL DISTENSION 58 0.0006
405 PANIC REACTION 4 0.0006
406 COLITIS 21 0.0006
407 TOOTHACHE 10 0.0006
408 MENTAL DISORDER 24 0.0006
409 MONOCYTE COUNT INCREASED 2 0.0006
410 ARTHRALGIA 229 0.0006
411 INJECTION SITE IRRITATION 7 0.0005
412 GASTROENTERITIS 8 0.0005
413 UTERINE LEIOMYOMA 4 0.0005
414 INJECTION SITE INJURY 3 0.0005
415 INFLUENZA 60 0.0005
416 LOCALISED INFECTION 13 0.0005
417 CELLULITIS 27 0.0005
418 MACULAR OEDEMA 3 0.0005
419 ARTHRITIS 42 0.0005
420 PAIN IN JAW 15 0.0005
421 PARANASAL SINUS DISCOMFORT 2 0.0005
422 HYPERTHERMIA 4 0.0005
423 PRODUCTIVE COUGH 25 0.0005
424 MUSCULOSKELETAL DISCOMFORT 9 0.0005
425 MALIGNANT MELANOMA 7 0.0005
426 CATARACT 31 0.0005
427 OSTEOARTHRITIS 22 0.0005
428 DEVICE INFORMATION OUTPUT ISSUE 4 0.0005
429 PELVIC FRACTURE 4 0.0005
430 AUTOIMMUNE DISORDER 5 0.0005
431 URINE ODOUR ABNORMAL 3 0.0005
432 NEOPLASM MALIGNANT 34 0.0005
433 OESOPHAGEAL PAIN 2 0.0005
434 DISEASE RECURRENCE 24 0.0005
435 GALLBLADDER DISORDER 9 0.0005
436 ODYNOPHAGIA 3 0.0005
437 MASS 7 0.0005
438 SKIN PAPILLOMA 2 0.0005
439 HEPATITIS B 3 0.0005
440 RHINITIS 4 0.0005
441 FRUSTRATION TOLERANCE DECREASED 4 0.0005
442 SPINAL FUSION SURGERY 2 0.0005
443 HYPERAESTHESIA 4 0.0005
444 BRONCHITIS 36 0.0005
445 CONCOMITANT DISEASE AGGRAVATED 3 0.0005
446 SPINAL STENOSIS 2 0.0005
447 CHOLANGITIS 3 0.0005
448 SOCIAL PROBLEM 2 0.0005
449 SKIN DISORDER 16 0.0005
450 BLOOD URINE PRESENT 9 0.0005
451 SCREAMING 3 0.0005
452 ESCHERICHIA URINARY TRACT INFECTION 2 0.0005
453 FACIAL PARALYSIS 4 0.0005
454 PURULENT DISCHARGE 2 0.0005
455 DEVICE BREAKAGE 19 0.0005
456 VITAMIN D DECREASED 4 0.0005
457 ROTATOR CUFF SYNDROME 6 0.0005
458 CARDIAC OPERATION 4 0.0005
459 INJECTION SITE BRUISING 37 0.0005
460 EAR PAIN 9 0.0005
461 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 3 0.0005
462 PYELONEPHRITIS 4 0.0005
463 CHAPPED LIPS 2 0.0005
464 TENDON DISORDER 3 0.0005
465 PARONYCHIA 2 0.0005
466 WALKING AID USER 3 0.0005
467 SINUS DISORDER 9 0.0005
468 PRODUCT COMMUNICATION ISSUE 4 0.0005
469 BLOOD CREATINE INCREASED 2 0.0005
470 FOOT DEFORMITY 5 0.0005
471 NERVE INJURY 5 0.0004
472 SKIN MASS 3 0.0004
473 MENINGITIS 3 0.0004
474 JOINT RANGE OF MOTION DECREASED 6 0.0004
475 TREATMENT FAILURE 37 0.0004
476 DYSSTASIA 13 0.0004
477 WRONG PRODUCT ADMINISTERED 3 0.0004
478 INFECTION 64 0.0004
479 ABDOMINAL HERNIA 2 0.0004
480 LUMBAR VERTEBRAL FRACTURE 2 0.0004
481 NIGHT SWEATS 14 0.0004
482 BLOOD PRESSURE DIASTOLIC INCREASED 2 0.0004
483 DIVERTICULITIS 12 0.0004
484 INJECTION SITE MASS 16 0.0004
485 HYPERTRANSAMINASAEMIA 3 0.0004
486 CONJUNCTIVITIS 8 0.0004
487 ARTHRITIS INFECTIVE 2 0.0004
488 ROSACEA 2 0.0004
489 VASCULITIS 5 0.0004
490 APPENDICITIS 4 0.0004
491 DIARRHOEA HAEMORRHAGIC 4 0.0004
492 BLOOD TEST ABNORMAL 6 0.0004
493 ACCIDENTAL EXPOSURE TO PRODUCT 44 0.0004
494 SQUAMOUS CELL CARCINOMA 4 0.0004
495 HAND FRACTURE 3 0.0004
496 COLITIS MICROSCOPIC 2 0.0004
497 GASTRIC ULCER 8 0.0004
498 ACCIDENT 5 0.0004
499 LOWER RESPIRATORY TRACT INFECTION 19 0.0004
500 DEVICE ISSUE 37 0.0004
501 ORAL HERPES 8 0.0004
502 SINUSITIS 42 0.0004
503 BLOOD PRESSURE DIASTOLIC DECREASED 3 0.0004
504 NASAL POLYPS 2 0.0004
505 TOOTH DISORDER 9 0.0004
506 HIP FRACTURE 13 0.0004
507 GASTROINTESTINAL SOUNDS ABNORMAL 2 0.0004
508 INJECTION SITE PRURITUS 27 0.0004
509 PULMONARY MASS 6 0.0004
510 SKIN LESION 11 0.0004
511 HEPATIC ENZYME ABNORMAL 2 0.0004
512 OVARIAN CYST 4 0.0004
513 SECRETION DISCHARGE 5 0.0004
514 MUSCLE ATROPHY 5 0.0004
515 CONSTIPATION 86 0.0004
516 PSORIATIC ARTHROPATHY 16 0.0004
517 WOUND 11 0.0004
518 ENDOCARDITIS 2 0.0004
519 INJECTION SITE WARMTH 8 0.0004
520 LYMPHOMA 6 0.0004
521 INJECTION SITE HAEMORRHAGE 31 0.0004
522 MUSCULOSKELETAL STIFFNESS 34 0.0004
523 POOR VENOUS ACCESS 4 0.0004
524 TENDERNESS 4 0.0004
525 MALABSORPTION 2 0.0004
526 PERIPHERAL SWELLING 59 0.0004
527 BRAIN FOG 6 0.0004
528 RHEUMATOID ARTHRITIS 43 0.0004
529 INCONTINENCE 4 0.0004
530 NASAL DISCOMFORT 3 0.0004
531 RENAL CYST 3 0.0004
532 BODY HEIGHT DECREASED 4 0.0004
533 GASTROINTESTINAL MOTILITY DISORDER 2 0.0004
534 SENSORY LOSS 3 0.0004
535 OVERWEIGHT 2 0.0004
536 MUSCLE DISORDER 3 0.0004
537 FAECES DISCOLOURED 8 0.0004
538 BACK INJURY 4 0.0004
539 SYSTEMIC LUPUS ERYTHEMATOSUS 13 0.0004
540 GINGIVAL BLEEDING 5 0.0004
541 ASPIRATION 4 0.0004
542 JAW DISORDER 2 0.0004
543 GASTROINTESTINAL PAIN 4 0.0004
544 AUTISM SPECTRUM DISORDER 2 0.0004
545 INJECTION SITE ERYTHEMA 45 0.0004
546 HYPERKERATOSIS 2 0.0004
547 PROSTATIC DISORDER 2 0.0004
548 INTRACRANIAL PRESSURE INCREASED 2 0.0004
549 INJECTION SITE RASH 11 0.0004
550 SKIN FISSURES 7 0.0004
551 GASTROINTESTINAL DISORDER 32 0.0004
552 INTESTINAL PERFORATION 4 0.0004
553 ACNE 27 0.0004
554 INTENTIONAL PRODUCT MISUSE 31 0.0004
555 SEASONAL ALLERGY 5 0.0004
556 SCAR 6 0.0004
557 CORONARY ARTERY BYPASS 2 0.0003
558 HERPES VIRUS INFECTION 2 0.0003
559 RESPIRATORY TRACT INFECTION 9 0.0003
560 RESPIRATORY SYNCYTIAL VIRUS INFECTION 3 0.0003
561 RALES 2 0.0003
562 SKIN WARM 2 0.0003
563 GROIN PAIN 3 0.0003
564 RHINORRHOEA 22 0.0003
565 BACK PAIN 79 0.0003
566 LYMPHADENOPATHY 12 0.0003
567 COVID-19 PNEUMONIA 4 0.0003
568 FATIGUE 262 0.0003
569 THERAPEUTIC PRODUCT EFFECT DECREASED 15 0.0003
570 GASTROINTESTINAL INFECTION 3 0.0003
571 THYROID CANCER 4 0.0003
572 OROPHARYNGEAL DISCOMFORT 3 0.0003
573 INJECTION SITE VESICLES 2 0.0003
574 PRESYNCOPE 8 0.0003
575 DISCOMFORT 20 0.0003
576 BRAIN NEOPLASM 3 0.0003
577 INCREASED TENDENCY TO BRUISE 3 0.0003
578 LIVER FUNCTION TEST INCREASED 7 0.0003
579 MENISCUS INJURY 2 0.0003
580 THYROID DISORDER 5 0.0003
581 ARTHROPATHY 18 0.0003
582 JOINT SWELLING 39 0.0003
583 PAIN 198 0.0003
584 MIDDLE INSOMNIA 6 0.0003
585 INTERVERTEBRAL DISC PROTRUSION 7 0.0003
586 NASAL DRYNESS 2 0.0003
587 SWELLING OF EYELID 2 0.0003
588 LIVER DISORDER 14 0.0003
589 RESPIRATORY TRACT CONGESTION 5 0.0003
590 SCIATICA 5 0.0003
591 LOWER LIMB FRACTURE 6 0.0003
592 INJECTION SITE INDURATION 4 0.0003
593 PLATELET COUNT INCREASED 4 0.0003
594 PHARYNGEAL SWELLING 3 0.0003
595 DECREASED IMMUNE RESPONSIVENESS 3 0.0003
596 LIGAMENT SPRAIN 3 0.0003
597 PHOTOSENSITIVITY REACTION 5 0.0003
598 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
599 DYSMENORRHOEA 4 0.0003
600 APPETITE DISORDER 2 0.0003
601 EYE HAEMORRHAGE 4 0.0003
602 PSORIASIS 39 0.0003
603 PERICARDITIS 5 0.0003
604 COUGH 83 0.0003
605 PALLOR 8 0.0003
606 ECCHYMOSIS 2 0.0003
607 INFLUENZA LIKE ILLNESS 24 0.0003
608 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 16 0.0003
609 LIMB DISCOMFORT 9 0.0003
610 PULMONARY OEDEMA 13 0.0003
611 THERAPEUTIC RESPONSE UNEXPECTED 13 0.0003
612 PROCEDURAL PAIN 8 0.0003
613 NEURALGIA 7 0.0003
614 DEVICE USE ERROR 10 0.0003
615 INJECTION SITE SWELLING 22 0.0003
616 SYRINGE ISSUE 5 0.0003
617 JOINT DISLOCATION 3 0.0003
618 RENAL PAIN 3 0.0003
619 CONTUSION 27 0.0003
620 PRODUCT SUPPLY ISSUE 2 0.0003
621 IRRITABLE BOWEL SYNDROME 6 0.0003
622 MOBILITY DECREASED 20 0.0003
623 SWELLING 26 0.0003
624 ABDOMINAL PAIN LOWER 7 0.0003
625 TONGUE DISORDER 2 0.0003
626 HYPERTHYROIDISM 4 0.0003
627 HAEMATEMESIS 7 0.0003
628 BIPOLAR DISORDER 3 0.0003
629 LIQUID PRODUCT PHYSICAL ISSUE 2 0.0003
630 PYREXIA 94 0.0003
631 PSYCHIATRIC SYMPTOM 2 0.0003
632 GAIT INABILITY 9 0.0003
633 SUNBURN 2 0.0003
634 BACTERIAL INFECTION 5 0.0003
635 DEAFNESS 7 0.0003
636 RASH PAPULAR 6 0.0003
637 OCULAR DISCOMFORT 3 0.0003
638 MALAISE 117 0.0003
639 GAIT DISTURBANCE 51 0.0003
640 PHOTOPHOBIA 5 0.0003
641 PAIN IN EXTREMITY 78 0.0003
642 DERMATITIS CONTACT 3 0.0003
643 ROAD TRAFFIC ACCIDENT 11 0.0003
644 MICTURITION URGENCY 3 0.0003
645 INTERNAL HAEMORRHAGE 3 0.0003
646 DRUG INEFFECTIVE 346 0.0003
647 HERPES ZOSTER 15 0.0003
648 NEOPLASM 3 0.0003
649 PROCEDURAL COMPLICATION 2 0.0003
650 PULMONARY FIBROSIS 5 0.0003
651 CONCUSSION 2 0.0003
652 ASTHENIA 96 0.0003
653 HYPOAESTHESIA 38 0.0003
654 ERYTHEMA 52 0.0003
655 UPPER LIMB FRACTURE 5 0.0003
656 ECZEMA 13 0.0002
657 NOCTURIA 3 0.0002
658 MATERNAL EXPOSURE DURING PREGNANCY 22 0.0002
659 BACK DISORDER 4 0.0002
660 INJECTION SITE EXTRAVASATION 3 0.0002
661 TENDON RUPTURE 3 0.0002
662 ABDOMINAL PAIN UPPER 50 0.0002
663 EYE SWELLING 9 0.0002
664 HAEMORRHAGE 25 0.0002
665 ANXIETY 68 0.0002
666 CHILLS 28 0.0002
667 FALL 79 0.0002
668 SKIN PLAQUE 2 0.0002
669 INTRAOCULAR PRESSURE INCREASED 3 0.0002
670 IMPAIRED WORK ABILITY 5 0.0002
671 HIATUS HERNIA 3 0.0002
672 MYOPATHY 2 0.0002
673 SKIN SWELLING 2 0.0002
674 SWELLING FACE 15 0.0002
675 NAIL DISORDER 2 0.0002
676 SPINAL OSTEOARTHRITIS 2 0.0002
677 PULMONARY CONGESTION 3 0.0002
678 GRIP STRENGTH DECREASED 2 0.0002
679 PURPURA 2 0.0002
680 HAEMOGLOBIN DECREASED 23 0.0002
681 ORAL PAIN 5 0.0002
682 WEIGHT DECREASED 62 0.0002
683 THROAT TIGHTNESS 6 0.0002
684 CHROMATURIA 5 0.0002
685 RASH PRURITIC 12 0.0002
686 LUPUS-LIKE SYNDROME 2 0.0002
687 TREATMENT NONCOMPLIANCE 12 0.0002
688 LUNG NEOPLASM MALIGNANT 9 0.0002
689 PERIPHERAL COLDNESS 3 0.0002
690 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 4 0.0002
691 PNEUMONIA BACTERIAL 2 0.0002
692 BLOOD PRESSURE INCREASED 33 0.0002
693 NECK PAIN 12 0.0002
694 ABDOMINAL DISCOMFORT 36 0.0002
695 RENAL DISORDER 10 0.0002
696 IMPAIRED HEALING 7 0.0002
697 SPINAL DISORDER 2 0.0002
698 GASTROOESOPHAGEAL REFLUX DISEASE 17 0.0002
699 OCULAR HYPERAEMIA 10 0.0002
700 VOMITING 99 0.0002
701 INSOMNIA 56 0.0002
702 PNEUMONIA 68 0.0002
703 SLEEP APNOEA SYNDROME 4 0.0002
704 PARALYSIS 3 0.0002
705 DIARRHOEA 135 0.0002
706 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
707 PANCREATITIS 11 0.0002
708 HYPERTENSION 44 0.0002
709 DECREASED APPETITE 48 0.0002
710 HEADACHE 129 0.0002
711 FIBROMYALGIA 5 0.0002
712 ABORTION SPONTANEOUS 8 0.0002
713 MIGRAINE 19 0.0002
714 BLINDNESS 8 0.0002
715 BODY TEMPERATURE INCREASED 4 0.0002
716 TINNITUS 9 0.0002
717 PERITONITIS 4 0.0002
718 FOLLICULITIS 2 0.0002
719 DYSURIA 7 0.0002
720 GENERAL PHYSICAL HEALTH DETERIORATION 22 0.0002
721 POOR QUALITY PRODUCT ADMINISTERED 2 0.0002
722 HEAD INJURY 6 0.0002
723 CYSTITIS 6 0.0002
724 LOSS OF CONSCIOUSNESS 24 0.0002
725 MOVEMENT DISORDER 6 0.0002
726 THROMBOSIS 15 0.0002
727 DYSPNOEA EXERTIONAL 7 0.0002
728 SKIN CANCER 4 0.0002
729 DRY MOUTH 15 0.0002
730 PRODUCT DISPENSING ERROR 4 0.0002
731 LUNG DISORDER 9 0.0002
732 PNEUMONITIS 5 0.0002
733 PULMONARY THROMBOSIS 2 0.0002
734 CHOLELITHIASIS 6 0.0002
735 DYSPEPSIA 18 0.0002
736 WHITE BLOOD CELL COUNT INCREASED 7 0.0002
737 URINARY TRACT INFECTION 31 0.0002
738 HEART RATE INCREASED 18 0.0002
739 TOOTH FRACTURE 2 0.0002
740 DRUG LEVEL INCREASED 3 0.0002
741 DENTAL CARIES 2 0.0002
742 HEPATOTOXICITY 4 0.0002
743 INCORRECT DOSE ADMINISTERED 41 0.0002
744 NAUSEA 142 0.0002
745 MALNUTRITION 2 0.0002
746 IMPAIRED DRIVING ABILITY 2 0.0002
747 SCAB 2 0.0002
748 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
749 SKIN IRRITATION 8 0.0002
750 MYOCARDITIS 2 0.0002
751 NERVOUSNESS 9 0.0002
752 RASH MACULAR 6 0.0002
753 BLOOD CHOLESTEROL INCREASED 8 0.0002
754 CARDIAC DISORDER 16 0.0002
755 HEART RATE DECREASED 6 0.0002
756 SPLENOMEGALY 2 0.0002
757 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 5 0.0002
758 DIABETES MELLITUS 13 0.0002
759 DEPRESSED MOOD 9 0.0002
760 DYSPHAGIA 16 0.0002
761 BACTERAEMIA 2 0.0002
762 PRODUCT PRESCRIBING ERROR 4 0.0002
763 RASH 73 0.0002
764 CHEST PAIN 31 0.0002
765 POLYNEUROPATHY 2 0.0002
766 PRODUCT DOSE OMISSION ISSUE 49 0.0002
767 DRUG INTOLERANCE 16 0.0002
768 CRYING 6 0.0002
769 PRODUCT USE ISSUE 31 0.0002
770 ADRENAL INSUFFICIENCY 2 0.0002
771 MYALGIA 28 0.0002
772 CYTOPENIA 2 0.0002
773 FEELING HOT 10 0.0002
774 INJECTION SITE URTICARIA 4 0.0002
775 ALOPECIA 32 0.0002
776 CARDIOMEGALY 2 0.0002
777 DIZZINESS 81 0.0002
778 EMOTIONAL DISORDER 5 0.0002
779 URTICARIA 27 0.0002
780 THINKING ABNORMAL 3 0.0002
781 DRY EYE 8 0.0002
782 BLISTER 9 0.0002
783 NERVOUS SYSTEM DISORDER 5 0.0002
784 HEPATITIS 4 0.0002
785 CHEST DISCOMFORT 16 0.0002
786 PRURITUS 60 0.0002
787 SLEEP DISORDER 11 0.0002
788 JOINT STIFFNESS 4 0.0002
789 WEIGHT INCREASED 34 0.0002
790 HAEMATOCRIT DECREASED 3 0.0002
791 BALANCE DISORDER 13 0.0002
792 FUNGAL INFECTION 5 0.0001
793 SYNCOPE 15 0.0001
794 DRY SKIN 20 0.0001
795 SINUS CONGESTION 2 0.0001
796 ANGER 5 0.0001
797 ARRHYTHMIA 7 0.0001
798 IMPAIRED GASTRIC EMPTYING 2 0.0001
799 MOOD ALTERED 4 0.0001
800 ALANINE AMINOTRANSFERASE INCREASED 9 0.0001
801 RASH ERYTHEMATOUS 7 0.0001
802 TACHYCARDIA 13 0.0001
803 POLLAKIURIA 6 0.0001
804 FEELING COLD 4 0.0001
805 HAEMOPTYSIS 4 0.0001
806 MYOCARDIAL INFARCTION 25 0.0001
807 RENAL IMPAIRMENT 12 0.0001
808 BLINDNESS UNILATERAL 2 0.0001
809 BRONCHOSPASM 2 0.0001
810 ANGINA PECTORIS 4 0.0001
811 LETHARGY 8 0.0001
812 PANCREATIC CARCINOMA 4 0.0001
813 ANOSMIA 2 0.0001
814 PULMONARY ARTERIAL HYPERTENSION 2 0.0001
815 HYPOKINESIA 2 0.0001
816 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
817 PRODUCT PRESCRIBING ISSUE 3 0.0001
818 SURGERY 8 0.0001
819 URINARY INCONTINENCE 4 0.0001
820 COLON CANCER 2 0.0001
821 GLOSSODYNIA 3 0.0001
822 SNEEZING 3 0.0001
823 RESPIRATORY DISORDER 4 0.0001
824 EPISTAXIS 10 0.0001
825 MUSCULOSKELETAL PAIN 7 0.0001
826 BLOOD POTASSIUM DECREASED 4 0.0001
827 LACRIMATION INCREASED 4 0.0001
828 HEPATIC ENZYME INCREASED 9 0.0001
829 HYPERHIDROSIS 17 0.0001
830 STOMATITIS 8 0.0001
831 SUICIDAL IDEATION 12 0.0001
832 MUSCULOSKELETAL CHEST PAIN 2 0.0001
833 THERAPY PARTIAL RESPONDER 2 0.0001
834 BASAL CELL CARCINOMA 2 0.0001
835 DEHYDRATION 17 0.0001
836 CYANOSIS 2 0.0001
837 ULCER 2 0.0001
838 MOOD SWINGS 4 0.0001
839 MUSCLE SPASMS 23 0.0001
840 FEELING ABNORMAL 30 0.0001
841 SENSORY DISTURBANCE 2 0.0001
842 EYE PAIN 7 0.0001
843 SEIZURE 14 0.0001
844 VISUAL IMPAIRMENT 15 0.0001
845 EYE PRURITUS 4 0.0001
846 TYPE 2 DIABETES MELLITUS 4 0.0001
847 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 4 0.0001
848 FLUID RETENTION 6 0.0001
849 ERECTILE DYSFUNCTION 3 0.0001
850 HAEMATURIA 4 0.0001
851 OEDEMA PERIPHERAL 14 0.0001
852 VERTIGO 7 0.0001
853 BURNING SENSATION 8 0.0001
854 COLD SWEAT 2 0.0001
855 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
856 LYMPHOCYTE COUNT DECREASED 2 0.0001
857 THIRST 2 0.0001
858 JAUNDICE 3 0.0001
859 PAIN OF SKIN 3 0.0001
860 OSTEOMYELITIS 2 0.0001
861 DEATH 95 0.0001
862 PELVIC PAIN 2 0.0001
863 UPPER RESPIRATORY TRACT INFECTION 5 0.0001
864 SEPSIS 12 0.0001
865 HEPATIC STEATOSIS 2 0.0001
866 HOT FLUSH 8 0.0001
867 FRACTURE 2 0.0001
868 MUSCULAR WEAKNESS 12 0.0001
869 DEPRESSION 24 0.0001
870 MUSCULOSKELETAL DISORDER 2 0.0001
871 ANAEMIA 20 0.0001
872 DYSPNOEA 59 0.0001
873 GLAUCOMA 2 0.0001
874 ERUCTATION 2 0.0001
875 DYSPHONIA 6 0.0001
876 VISION BLURRED 14 0.0001
877 INJECTION SITE REACTION 7 0.0001
878 PARAESTHESIA 16 0.0001
879 LABORATORY TEST ABNORMAL 3 0.0001
880 IRRITABILITY 6 0.0001
881 FULL BLOOD COUNT DECREASED 2 0.0001
882 CORONARY ARTERY DISEASE 3 0.0001
883 NEUTROPHIL COUNT DECREASED 4 0.0001
884 BREAST CANCER 9 0.0001
885 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 5 0.0001
886 GASTROINTESTINAL HAEMORRHAGE 8 0.0001
887 SPEECH DISORDER 5 0.0001
888 SOMNOLENCE 19 0.0001
889 RETCHING 2 0.0001
890 DISTURBANCE IN ATTENTION 5 0.0001
891 OEDEMA 5 0.0001
892 HYPERSENSITIVITY 17 0.0001
893 OSTEONECROSIS 3 0.0001
894 INTENTIONAL PRODUCT USE ISSUE 8 0.0001
895 EYE DISORDER 3 0.0001
896 STAPHYLOCOCCAL INFECTION 3 0.0001
897 MELAENA 2 0.0001
898 ANAPHYLACTIC REACTION 5 0.0001
899 OXYGEN SATURATION DECREASED 5 0.0001
900 SKIN DISCOLOURATION 4 0.0001
901 MUSCLE TWITCHING 2 0.0001
902 NEUROPATHY PERIPHERAL 8 0.0001
903 COMA 4 0.0001
904 CEREBRAL HAEMORRHAGE 3 0.0001
905 DIABETIC KETOACIDOSIS 2 0.0001
906 WHITE BLOOD CELL COUNT DECREASED 9 0.0001
907 SKIN EXFOLIATION 7 0.0001
908 MENTAL IMPAIRMENT 2 0.0001
909 PANIC ATTACK 3 0.0001
910 RESTLESSNESS 3 0.0001
911 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
912 AGGRESSION 4 0.0001
913 HYPOPHAGIA 2 0.0001
914 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0001
915 SKIN ULCER 2 0.0001
916 AMNESIA 5 0.0001
917 DISORIENTATION 3 0.0001
918 BREAST CANCER FEMALE 2 0.0001
919 CARDIAC FAILURE CONGESTIVE 6 0.0001
920 MENSTRUATION IRREGULAR 2 0.0001
921 PROSTATE CANCER 6 0.0001
922 CONFUSIONAL STATE 12 0.0001
923 DEMENTIA 2 0.0001
924 WITHDRAWAL SYNDROME 3 0.0001
925 CEREBROVASCULAR ACCIDENT 12 0.0001
926 ASTHMA 8 0.0001
927 HYPERSOMNIA 2 0.0001
928 VAGINAL HAEMORRHAGE 3 0.0001
929 PALPITATIONS 8 0.0001
930 BONE PAIN 4 0.0001
931 ASCITES 2 0.0001
932 THROAT IRRITATION 3 0.0001
933 THERAPY NON-RESPONDER 3 0.0001
934 TREMOR 11 0.0001
935 MEMORY IMPAIRMENT 9 0.0001
936 EPILEPSY 2 0.0001
937 HYPOTENSION 13 0.0001
938 FEMUR FRACTURE 2 0.0001
939 COGNITIVE DISORDER 3 0.0001
940 SWOLLEN TONGUE 2 0.0001
941 CARDIAC FAILURE 5 0.0001
942 INFUSION RELATED REACTION 4 0.0001
943 RENAL FAILURE 8 0.0001
944 LIP SWELLING 2 0.0001
945 LEUKOPENIA 3 0.0001
946 GASTRIC DISORDER 2 0.0001
947 NIGHTMARE 2 0.0001
948 DELIRIUM 2 0.0001
949 INJURY 4 0.0001
950 HEPATIC FUNCTION ABNORMAL 2 0.0001
951 PULMONARY EMBOLISM 5 0.0001
952 PRODUCT SUBSTITUTION ISSUE 3 0.0001
953 BLADDER CANCER 3 0.0001
954 WHEEZING 3 0.0001
955 SUICIDE ATTEMPT 3 0.0000
956 PLEURAL EFFUSION 3 0.0000
957 OSTEOPOROSIS 2 0.0000
958 HYPOACUSIS 2 0.0000
959 SEPTIC SHOCK 2 0.0000
960 BLOOD CREATININE INCREASED 3 0.0000
961 ADVERSE DRUG REACTION 4 0.0000
962 DISEASE PROGRESSION 5 0.0000
963 SKIN BURNING SENSATION 3 0.0000
964 BLOOD GLUCOSE DECREASED 2 0.0000
965 UNDERDOSE 3 0.0000
966 AGITATION 3 0.0000
967 DYSGEUSIA 3 0.0000
968 PRODUCT USE IN UNAPPROVED INDICATION 10 0.0000
969 DERMATITIS ATOPIC 2 0.0000
970 BRADYCARDIA 2 0.0000
971 THROMBOCYTOPENIA 4 0.0000
972 PRODUCT STORAGE ERROR 3 0.0000
973 THERAPEUTIC RESPONSE DECREASED 2 0.0000
974 DEEP VEIN THROMBOSIS 2 0.0000
975 BLOOD PRESSURE DECREASED 2 0.0000
976 PLATELET COUNT DECREASED 3 0.0000
977 THERAPY INTERRUPTED 2 0.0000
978 CHRONIC KIDNEY DISEASE 2 0.0000
979 CARDIAC ARREST 2 0.0000
980 BLOOD GLUCOSE INCREASED 4 0.0000
981 ATRIAL FIBRILLATION 2 0.0000
982 FLUSHING 2 0.0000
983 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
984 OVERDOSE 3 0.0000
985 ACUTE KIDNEY INJURY 2 0.0000
986 HOSPITALISATION 2 0.0000
987 TOXICITY TO VARIOUS AGENTS 2 0.0000
988 NO ADVERSE EVENT 2 0.0000